Navarixin
≥98%
- Product Code: 67704
CAS:
473727-83-2
| Molecular Weight: | 397.42 g./mol | Molecular Formula: | C₂₁H₂₃N₃O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Navarixin is primarily used in the field of medical research and therapy development, particularly in the treatment of inflammatory diseases and certain types of cancer. It functions as a selective antagonist of the CXCR1 and CXCR2 chemokine receptors, which play a significant role in the recruitment of immune cells to sites of inflammation. By blocking these receptors, Navarixin helps reduce inflammation and can potentially slow the progression of diseases where inflammation is a key factor, such as chronic obstructive pulmonary disease (COPD) and rheumatoid arthritis. Additionally, its ability to inhibit these receptors makes it a candidate for research in cancer therapy, as it may help in controlling tumor growth and metastasis by limiting the migration of cancer cells and the formation of new blood vessels that supply tumors.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | €433.09 |
+
-
|
| 0.010 | 10-20 days | €703.77 |
+
-
|
Navarixin
Navarixin is primarily used in the field of medical research and therapy development, particularly in the treatment of inflammatory diseases and certain types of cancer. It functions as a selective antagonist of the CXCR1 and CXCR2 chemokine receptors, which play a significant role in the recruitment of immune cells to sites of inflammation. By blocking these receptors, Navarixin helps reduce inflammation and can potentially slow the progression of diseases where inflammation is a key factor, such as chronic obstructive pulmonary disease (COPD) and rheumatoid arthritis. Additionally, its ability to inhibit these receptors makes it a candidate for research in cancer therapy, as it may help in controlling tumor growth and metastasis by limiting the migration of cancer cells and the formation of new blood vessels that supply tumors.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :